CrossrefInfokarte
Riluzole: real-world evidence supports significant extension of median survival times in patients with amyotrophic lateral sclerosis
Degenerative Neurological and Neuromuscular Disease · 2017
DOI: 10.2147/dnnd.s135748 ↗Abstract
Kein Abstract verfügbar.
EUVIMED